
Sol-Gel Technologies (SLGL) Stock Forecast & Price Target
Sol-Gel Technologies (SLGL) Analyst Ratings
Bulls say
Sol-Gel Technologies is attractive because its lead asset, SGT-610, addresses a severe unmet need in Gorlin syndrome, where patients can develop dozens or even hundreds of BCCs and rely on repeated, painful, costly surgeries with no approved therapy. The upcoming Phase 3 top-line readout, in a 113-patient randomized, double-blind, vehicle-controlled study with 102 completers, is a major catalyst, and the bullish case is strengthened by a focused PTCH1+ population, a prior post hoc signal showing 48% fewer new BCCs, and a potential U.S. population of roughly 11-12K diagnosed patients. Financially, the company’s ~$52.8M cash and marketable securities, ~$33.1M March 2026 financing, and additional TWYNEO/EPSOLAY partnership royalties support development while preserving optionality for long-term upside.
Bears say
Sol-Gel Technologies is facing a fundamentally weak investment case because its SGT-610 Phase 3 is essentially a redo of PellePharm’s failed 2021 study, which missed statistical significance on the primary endpoint with p=0.73. The company also bought the asset for only about $5M upfront in 2023, underscoring limited prior conviction, while the current trial remains exposed to replication risk, highly variable lesion counts, and an endpoint that may not deliver a durable treatment effect even if it succeeds statistically. Commercially, approval would still not ensure meaningful revenue because physician adoption and reimbursement are uncertain, and the company remains concentrated in the United States.
This aggregate rating is based on analysts' research of Sol-Gel Technologies and is not a guaranteed prediction by Public.com or investment advice.
Sol-Gel Technologies (SLGL) Analyst Forecast & Price Prediction
Start investing in Sol-Gel Technologies (SLGL)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Sol-Gel Technologies (SLGL) Forecast
Sol-Gel Technologies (SLGL) Analyst Forecast & Price Prediction
Start investing in Sol-Gel Technologies (SLGL)
Order type
Buy in
Order amount
Est. shares
0 shares